SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-08-035621
Filing Date
2008-05-23
Accepted
2008-05-23 16:03:33
Documents
5
Period of Report
2008-03-07
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A a08-15147_18ka.htm 8-K/A 1760748
2 EX-23.1 a08-15147_1ex23d1.htm EX-23.1 3256
3 GRAPHIC g151471ba05i001.jpg GRAPHIC 20348
4 GRAPHIC g151471ba05i002.jpg GRAPHIC 13825
5 GRAPHIC g151471ba03i001.jpg GRAPHIC 7461
  Complete submission text file 0001104659-08-035621.txt   1823440
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-15006 | Film No.: 08858329
SIC: 2835 In Vitro & In Vivo Diagnostic Substances